<html>
<head>PUBMED IDs for ADAM29</head>
<body bgcolor='#C5F0F2'><h1>ADAM29</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10512762/'>Isolation of two novel metalloproteinase-disintegrin (ADAM) cDNAs that show testis-specific gene expression.</a> October 8  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10644455/'>Molecular cloning and mapping of a novel ADAM gene (ADAM29) to human chromosome 4.</a> January 25  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12463424/'>Screen and identification of proteins interacting with ADAM19 cytoplasmic tail.</a> December 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15802535/'>The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia.</a> April 2  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16840197/'>Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia.</a> July 15  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/19340428/'>IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/21618342/'>Analysis of the disintegrin-metalloproteinases family reveals ADAM29 and ADAM7 are often mutated in melanoma.</a> September 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/25036638/'>Systematic identification of barriers to human iPSC generation.</a> October 22  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26977022/'>ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.</a> November 8  2016<br></body></html>
